ERBB2 and breast cancer: Triple‐negative breast cancer (TNBC) cells do not express oestrogen receptor (ER), progesterone receptor (PR) or human epidermal growth factor receptor 2 (HER2)2 and account for 15‐26% of breast cancer cases.3, 4